An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy.
- DOI
- 10.1021/jacs.5c17801
- Published
- 2026 Feb 25
- Container
- Journal of the American Chemical Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/jacs.5c17801,
title = {An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy.},
author = {Xiao Y and Zhou X and Niu X and Ye X and Chen D and Dong Q and He Z and Yang X and Wang M and Zeng W and Su Y and Luo F and Liu J and Gao Y},
year = {2026},
journal = {Journal of the American Chemical Society},
doi = {10.1021/jacs.5c17801},
url = {https://doi.org/10.1021/jacs.5c17801}
}RIS
TY - JOUR TI - An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy. AU - Xiao Y AU - Zhou X AU - Niu X AU - Ye X AU - Chen D AU - Dong Q AU - He Z AU - Yang X AU - Wang M AU - Zeng W AU - Su Y AU - Luo F AU - Liu J AU - Gao Y PY - 2026 JO - Journal of the American Chemical Society DO - 10.1021/jacs.5c17801 UR - https://doi.org/10.1021/jacs.5c17801 ER -
APA
Y, X., X, Z., X, N., X, Y., D, C., Q, D., Z, H., X, Y., M, W., W, Z., Y, S., F, L., J, L., & Y, G. (2026). An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy.. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c17801
Source records
- pubmed · retrieved 2026-11-10T10:41:31.461Z